cyproheptadine hydrochloride - Profile

What are the generic drug sources for cyproheptadine hydrochloride and what is the scope of patent protection?

Cyproheptadine hydrochloride is the generic ingredient in two branded drugs marketed by Actavis Mid Atlantic, Chartwell Molecular, Halsey, Morton Grove, Naska, Patrin, Pharm Assoc, Quagen, Rising, St John Pharm, Tris Pharma Inc, Merck, Am Therap, Appco, Ascot, Chartwell Rx, Duramed Pharms Barr, Heritage Pharma, Ingenus Pharms Llc, Kenton, Kv Pharm, Md Pharm, Mountain, Mylan, Pioneer Pharms, Pliva, Regcon Holdings, Strides Pharma Intl, Superpharm, Vitarine, Watson Labs, and Zydus Pharms, and is included in forty-one NDAs. Additional information is available in the individual branded drug profile pages.

Summary for cyproheptadine hydrochloride

US Patents:	0
Tradenames:	2
Applicants:	32
NDAs:	41

US Patents and Regulatory Information for cyproheptadine hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Mid Atlantic	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	SYRUP;ORAL	086833-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Chartwell Molecular	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	SYRUP;ORAL	203191-001	Jul 13, 2017	AA	RX	No	No
Halsey	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	SYRUP;ORAL	089199-001	Jul 3, 1986		DISCN	No	No
Morton Grove	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	SYRUP;ORAL	087001-001	Nov 4, 1982		DISCN	No	No
Naska	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	SYRUP;ORAL	089021-001	Dec 21, 1987		DISCN	No	No
Patrin	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	SYRUP;ORAL	204823-001	Dec 27, 2016		DISCN	No	No
Pharm Assoc	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	SYRUP;ORAL	091295-001	Mar 28, 2013		DISCN	No	No